Hostname: page-component-54dcc4c588-9xpg2 Total loading time: 0 Render date: 2025-10-11T18:16:21.544Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive function and cannabis use in first episodes of psychosis

Published online by Cambridge University Press:  26 August 2025

P. Fuentes-Pérez ,
P. Cordero Andrés ,
C. Ovejas-Catalán ,
R. Pérez Iglesias ,
P. Suárez Pinilla ,
C. Flor Gómez ,
D. De la Sierra Biddle ,
M. L. Ramírez Bonilla  and
J. Vázquez-Bourgon
P. Fuentes-Pérez*
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL
P. Cordero Andrés
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL Psychiatry Department, University Hospital Marqués de Valdecilla
C. Ovejas-Catalán
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL
R. Pérez Iglesias
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL Psychiatry Department, University Hospital Marqués de Valdecilla University of Cantabria, Santander, Spain
P. Suárez Pinilla
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL Psychiatry Department, University Hospital Marqués de Valdecilla University of Cantabria, Santander, Spain
C. Flor Gómez
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL Psychiatry Department, University Hospital Marqués de Valdecilla
D. De la Sierra Biddle
Affiliation:
Psychiatry Department, University Hospital Marqués de Valdecilla
M. L. Ramírez Bonilla
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL Psychiatry Department, University Hospital Marqués de Valdecilla
J. Vázquez-Bourgon
Affiliation:
Valdecilla Biomedical Research Institute - IDIVAL Psychiatry Department, University Hospital Marqués de Valdecilla University of Cantabria, Santander, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The association between cannabis use and cognitive functioning in individuals experiencing a first episode of psychosis (FEP) is inconsistent, with some studies reporting deterioration (Bogaty et al. J Psychiatr Res 2018; 99:22-32), others indicating improved performance (Rodríguez-Sánchez et al. Schizophr Res 2010; 124:142-151), and some finding no difference.

Objectives

This study aims to evaluate the effect of cannabis use on cognitive functioning among individuals diagnosed with FEP.

Methods

A cross-sectional study was conducted on FEP patients enrolled in the ITPCan Program (Santander, Spain) between January 2020 and July 2024. A total of 207 participants (57 cannabis users and 145 non-users) with a FEP diagnosis were included. A descriptive-univariate analysis was performed on clinical, analytical, and cognitive variables. A Student’s t-test compared baseline cognitive performance between cannabis users and non-users, while a multivariate general linear model (GLM) assessed differences related to cannabis consumption, adjusting for sex, age, and educational level. Statistical analyses were performed using SPSS.

Results

Out of the 207 FEP participants, 53.6% were women, with an average age of 36.8 years. Cannabis users comprised 28.1% of the group, and present at baseline a lower mean age at intake (27 years; p < 0.001). Cannabis users exhibited significantly higher scores in mania and positive psychotic symptoms. Cognitive assessments, completed by 148 patients (39 users and 108 non-users), revealed that cannabis users performed better than non-users on “processing speed” task; however, after adjusting for sex, age, and educational level, these differences were attributed to educational level and sex.

Conclusions

In consonance with some previous studies (Sánchez-Gutiérrez et al. Eur Psychiatry 2020; 63(1)), cannabis use does not appear to be a determining factor in cognitive performance in early psychosis.

Disclosure of Interest

None Declared

Information

Type
Abstract
Information
European Psychiatry , Volume 68 , Special Issue S1: Abstracts of the 33rd European Congress of Psychiatry , April 2025 , pp. S832
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.